| Authors: |
Jones N; INSERM U1218, University of Bordeaux, Institut Bergonié, Bordeaux, France; Cancer Genetics Unit, Institut Bergonié, Bordeaux, France., Gros A; INSERM U1218, University of Bordeaux, Institut Bergonié, Bordeaux, France; Cancer Genetics Unit, Institut Bergonié, Bordeaux, France., Velasco V; Pathology Department, Institut Bergonié, Bordeaux, France., Dapremont V; Biological Resource Centre, Institut Bergonié, Bordeaux, France., Brouste V; Clinical & Epidemiological Research Unit, Institut Bergonié, Bordeaux, France., Gastaldello B; Cancer Genetics Unit, Institut Bergonié, Bordeaux, France., Debled M; Medical Oncology Department, Institut Bergonié, Bordeaux, France., Tunon de Lara C; Department of Surgery, Institut Bergonié, Bordeaux, France., Bonnet F; INSERM U1218, University of Bordeaux, Institut Bergonié, Bordeaux, France; Cancer Genetics Unit, Institut Bergonié, Bordeaux, France., Barouk-Simonet E; Cancer Genetics Unit, Institut Bergonié, Bordeaux, France., Bubien V; Cancer Genetics Unit, Institut Bergonié, Bordeaux, France., Venat L; Medical Oncology Department, Dupuytren University Hospital, Limoges, France., MacGrogan G; INSERM U1218, University of Bordeaux, Institut Bergonié, Bordeaux, France; Pathology Department, Institut Bergonié, Bordeaux, France., Longy M; INSERM U1218, University of Bordeaux, Institut Bergonié, Bordeaux, France; Cancer Genetics Unit, Institut Bergonié, Bordeaux, France., Sevenet N; INSERM U1218, University of Bordeaux, Institut Bergonié, Bordeaux, France; Cancer Genetics Unit, Institut Bergonié, Bordeaux, France; Faculty of Pharmacy, Univ. Bordeaux, Bordeaux, France. Electronic address: n.sevenet@bordeaux.unicancer.fr. |